BR

Babita Rao

Active Director Director DIN 06360273
DIN 06360273 First appointment Aug 2012 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2012
Shareholding value •••• Premium profile

About Babita Rao

Data last updated:

Babita Rao is a Director at Lifekind Pharmaceuticals Private Limited (since 2012). The company operates in Trading. Lifekind Pharmaceuticals Private Limited reported revenue of ₹25.9 Lakh (FY 2017).

DIN 06360273
Primary Designation Director
Industry Trading
First Appointment 21 Aug 2012
Oldest Company Age 15 yrs
Largest company Lifekind Pharmaceuticals Private Limited · ₹25.9 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Aug 20122011₹25.9 Lakh (FY 2017)Active

Board colleagues of Babita Rao

Directorship timeline

Open interactive timeline →
Lifekind Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Babita Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babita Rao

Babita Rao currently holds 1 directorship: Lifekind Pharmaceuticals Private Limited (Director, since 21 Aug 2012, revenue ₹25.9 Lakh (FY 2017)).

Babita Rao was first appointed on 21 Aug 2012 as Director at Lifekind Pharmaceuticals Private Limited.

The current boards of Babita Rao's companies include Amar Nath Choudhary (Lifekind Pharmaceuticals Private Limited), Anurag Singh (Lifekind Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available